Eli Lilly stock slides after-hours after $2.4 billion Orna deal — what to watch next for LLY
Eli Lilly shares fell 1.3% to $1,044.67 in after-hours trading Monday after the company announced a deal to acquire Orna Therapeutics for up to $2.4 billion. The all-cash purchase includes milestone payments tied to clinical development. Investors are watching for updates on Orna’s cell therapy programs and regulatory decisions on Lilly’s obesity drug pipeline.